Acute Leukemias Flashcards
The gene fusion in APL fuses the ______ to another, so differentiation is blocked.
retinoic acid receptor-alpha (RARA) gene
What is an Auer rod?
small, stick-like structures in the cytoplasm
What is the treatment for APL?
retinoic acid and arsenic salts
In megakaryoblastic differentiation AML, the leukemic cells may express megakaryocytic antigens ____ and ____.
CD41, CD61
AML with t(1;22) RBM15-MKL1 shows _____ and is most often seen in _____.
megakaryoblastic differentiation; infants with Down Syndrome
B-ALL with abnormalities of _____ is frequently seen in neonates and young infants.
11q23 MLL
In AML with inv(16) or t(16;16) CBFB-MYH11, there is usually a mixture of increased ____ and _____.
myeloblasts; monocytes
Chromosomal abnormalities are found in 95% of ____ and 90% of ______.
AML patients; ALL patients
______ are found in 95% of AML patients and 90% of ALL patients.
Chromosomal abnormalities
What does CEBPA indicate?
positive AML,NOS
T-ALL frequently presents with lymphoblastic lymphoma, often manifesting as a ____.
large mediastinal mass
What is therapy related AML (t-AML)?
AML arising 2a to DNA damage from a prior therapy, like DNA alkylating agents, topo-II inhibitors, or ionizing radiation
Chemotherapy, especially with _____ and ____, is a risk factor for acute leukemia.
DNA alkylating agents; topoisomerase-II inhibitors
____ more frequently occurs in adolescents and young adults.
T-ALL
What are the 5 AML chromosome translocations?
- t(8;21) RUNX1-RUNX1T1 2. inv(16) or t(16;16) CBFB-MYH11 3. t(15;17) PML-RARA APL 4. t(1;22) RBM15-MKL1 5. 11q23 MLL
What is Fanconi Anemia?
inherited aplastic anemia; auto recessive or x-linked;
What is the incidence of AML?
3/100,000
t-AML 2a to topoisomerase-II inhibitors usually has a latency period of ____ and has a karyotype showing _____.
1-2 years; rearrangement of the MLL gene
T-ALL frequently presents with _____, often manifesting as a large mediastinal mass.
lymphoblastic lymphoma
In adults, ALL has a remission rate of ____ and cure rates of _____.
60-80%; less than 50%
What is the prognosis in t(1;22) RBM15-MKL1? Treatment?
relatively good; intensive chemo
___% of all cases of ALL occur in children under 6yo.
75
Some cases of APL give rise to ____, which the clinician should always be watching for.
DIC
What is the average age of AML diagnosis?
65yo
What are the signs of acute anemia?
anemia, pallor, thrombocytopenia, hemorrhage, ecchymoses, petechiae, fever, infection, adenopathy, hepatosplenomegaly, medistinal mass
75% of all cases of ALL occur in _____.
children under 6yo
B-ALL with _____ accounts for 25% of childhood cases and have a very favorable prognosis.
t(12;21) ETV-6RUNX1
In _____, the leukemic cells can express monocytic antigens CD64 and CD14.
monocytic differentiation AML
Acute leukemia is ____.
a clonal, neoplastic proliferation of immature myeloid or lymphoid cells
In ____, the leukemic cells may express megakaryocytic antigens CD41 and CD61.
megakaryoblastic differentiation AML
T-ALL accounts for ____% of ALL cases.
25-30
What does CBFB do?
encodes the beta subunit of core binding factor (CBF)
ALL has a good prognosis in _____; the complete remission rate is 95% and cure rates are about 80%.
children
AML with 11q23 MLL shows some degree of _____ and has a ____ prognosis.
monocytic differentiation; poor
What are the diagnostic criteria for AML?
increased myeloblasts accounting for >20% of nucleated cells
What are the symptoms of acute anemia?
fatigue, malaise, dyspnea, bruising, weight loss, bone or ab pain, neuro symptoms
Which gene encodes for the alpha unit of core binding factor (CBF), a transcription factor needed for hematopoiesis?
RUNX1